Mi
MiRXES
Singapore SGFounded 2014100 employees
Private CapbiotechPrivateOncology
Platform: miRNA Dx Gastric
Market Cap
N/A
All Drugs
3
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Sotomavacamten | MIR-168 | NDA/BLA | 1 | TIM-3 | NSCLCPNH | ||
| MIR-8412 | MIR-8412 | Phase 1/2 | 1 | APOC3 | OCDEndometrial Ca | ||
| MIR-1203 | MIR-1203 | Phase 1 | 2 | PD-1 | DravetObesity |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (3)